In its filing, Wipro notified the exchange about its collaboration with the Centre for Brain Research (CBR) at the Indian Institute of Science (IISc) Bengaluru to create a personal care engine that uses artificial intelligence (AI) to lower and control the risk of cardiovascular disease.
The cooperation will create new technologies for the treatment and prevention of long-term health conditions, as well as to give precision assistance for these diseases, according to the business that announced the agreement on earlier today.
The business stated that by leveraging AI to tailor its interactions with users and optimise for their long-term health and wellbeing, the personal care engine will reduce and manage the risk of cardiovascular disease and associated neurological illnesses.
In partnership with CBR at IISc, Wipro will test the engine through a digital app-based experiment. According to the corporation, the main goal of this collaboration is to create big data analytics, machine learning (ML) and artificial intelligence (AI).
We are thrilled to be embarking on this adventure in partnership with the CBR and IISc. Wide-ranging applications and advantages for health management are made possible by our personal care engine. According to Wipro Limited Chief Technology Officer Subha Tatavarti, “it has the potential to mitigate lifestyle-related conditions and even enhance cognitive and psychosocial functioning.”
Wipro announced that as part of Lab45, its research and development (R&D) team will create a personal care engine, or artificial intelligence (AI) system that considers a person’s past medical history, desired health state, and other behavioural responses in order to encourage healthy ageing, positive lifestyle choices, and psycho-social wellbeing in order to gradually improve a person’s health.
Our partnership with CBR will lead the way in developing innovative solutions at the nexus of cognitive sciences and computers, providing scalable personalised care assistance for some of the world’s most pressing chronic health issues. Dr. Ajay Chander, Head of Research and Development at Wipro Limited, stated, “We are particularly focused on cardiovascular diseases because of their high correlation with long-term cognitive disorders and the potential for wide health and wellness benefits at reduced prices.
Important data about the engine’s efficacy in situations that are very pertinent to long-term health outcomes will be produced by this experiment. Combining CBR’s cutting-edge brain science research with Wipro’s technology know-how will open up new avenues for patient care, cognitive function, and general wellness.
By collaborating with Wipro, we can leverage large-scale digital applications to further our scientific knowledge. Professor K.V.S. Hari, Director of the Centre for Brain Research, stated that this collaboration will quicken the transition from basic science to practical applications in cognitive and general health.
Both schools’ combined R&D capabilities will enable the development of solutions that improve population-level health outcomes.
-Raja Aditya
